Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 413

1.

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.

Zweegman S, Stege CAM, Haukas E, Schjesvold FH, Levin MD, Waage A, Leys RBL, Klein SK, Szatkowski D, Axelsson P, Hieu Do T, Knut-Bojanowska D, van der Spek E, Svirskaite A, Klostergaard A, Salomo M, Blimark C, Ypma PF, Mellqvist UH, Poddighe PJ, Stevens-Kroef M, van de Donk NWCJ, Sonneveld P, Hansson M, van der Holt B, Abildgaard N.

Haematologica. 2020 Feb 13. pii: haematol.2019.240374. doi: 10.3324/haematol.2019.240374. [Epub ahead of print] No abstract available.

2.

Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities.

Stege CAM, van der Holt B, Dinmohamed AG, Sonneveld P, Levin MD, van de Donk NWCJ, Mellqvist UH, Waage A, Zweegman S.

Leukemia. 2020 Jan 22. doi: 10.1038/s41375-020-0713-4. [Epub ahead of print] No abstract available.

PMID:
31969670
3.

Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance.

Kalin B, Ter Borg M, Wijers R, Somers JAE, van der Holt B, van Bergen CAM, Petersen EJ, Kuball J, Meijer E, Schaap NPM, Zeerleder SS, Broers AE, Braakman E, Falkenburg JHF, Lamers CHJ, Cornelissen JJ.

Hemasphere. 2019 Aug 9;3(5):e285. doi: 10.1097/HS9.0000000000000285. eCollection 2019 Oct. No abstract available.

4.

The florigen interactor BdES43 represses flowering in the model temperate grass Brachypodium distachyon.

Cao S, Luo X, Xie L, Gao C, Wang D, Holt BF 3rd, Lin H, Chu C, Xia X.

Plant J. 2019 Nov 29. doi: 10.1111/tpj.14622. [Epub ahead of print]

PMID:
31782581
5.

Endoscopic mucosal resection is effective for laterally spreading lesions at the anorectal junction.

Shahidi N, Sidhu M, Vosko S, van Hattem WA, Bar-Yishay I, Schoeman S, Tate DJ, Holt B, Hourigan LF, Lee EY, Burgess NG, Bourke MJ.

Gut. 2019 Nov 12. pii: gutjnl-2019-319785. doi: 10.1136/gutjnl-2019-319785. [Epub ahead of print]

PMID:
31719129
6.

Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures.

Schulberg JD, Wright EK, Holt BA, Sutherland TR, Hume SJ, Hamilton AL, Ross AL, Connell WC, Brown SJ, Lust M, Miller AM, Bell SJ, Kamm MA.

J Gastroenterol Hepatol. 2019 Oct 31. doi: 10.1111/jgh.14908. [Epub ahead of print]

PMID:
31674069
7.

Building mountain biodiversity: Geological and evolutionary processes.

Rahbek C, Borregaard MK, Antonelli A, Colwell RK, Holt BG, Nogues-Bravo D, Rasmussen CMØ, Richardson K, Rosing MT, Whittaker RJ, Fjeldså J.

Science. 2019 Sep 13;365(6458):1114-1119. doi: 10.1126/science.aax0151. Review.

PMID:
31515384
8.

Humboldt's enigma: What causes global patterns of mountain biodiversity?

Rahbek C, Borregaard MK, Colwell RK, Dalsgaard B, Holt BG, Morueta-Holme N, Nogues-Bravo D, Whittaker RJ, Fjeldså J.

Science. 2019 Sep 13;365(6458):1108-1113. doi: 10.1126/science.aax0149. Review.

PMID:
31515383
9.

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study.

Nielsen LK, Stege C, Lissenberg-Witte B, van der Holt B, Mellqvist UH, Salomo M, Bos G, Levin MD, Visser-Wisselaar H, Hansson M, van der Velden A, Deenik W, Coenen J, Hinge M, Klein S, Tanis B, Szatkowski D, Brouwer R, Westerman M, Leys R, Sinnige H, Haukås E, van der Hem K, Durian M, Gimsing P, van de Donk N, Sonneveld P, Waage A, Abildgaard N, Zweegman S.

Haematologica. 2019 Sep 12. pii: haematol.2019.222299. doi: 10.3324/haematol.2019.222299. [Epub ahead of print]

10.

Deconvolving multiplexed protease signatures with substrate reduction and activity clustering.

Zhuang Q, Holt BA, Kwong GA, Qiu P.

PLoS Comput Biol. 2019 Sep 3;15(9):e1006909. doi: 10.1371/journal.pcbi.1006909. eCollection 2019 Sep.

11.

Immunoinflammatory responses to febrile lower respiratory infections in infants display uniquely complex/intense transcriptomic profiles.

Jones AC, Anderson D, Galbraith S, Fantino E, Cardenas DG, Read JF, Serralha M, Holt BJ, Strickland DH, Sly PD, Bosco A, Holt PG.

J Allergy Clin Immunol. 2019 Nov;144(5):1411-1413. doi: 10.1016/j.jaci.2019.07.043. Epub 2019 Aug 19. No abstract available.

PMID:
31437489
12.

Rare Presentation of Endocarditis and Mycotic Brain Aneurysm.

Beckerman Z, Martínez-Bravo LE, Johnson G, Holt B, Fraser CD.

Ann Thorac Surg. 2019 Aug 16. pii: S0003-4975(19)31173-7. doi: 10.1016/j.athoracsur.2019.06.073. [Epub ahead of print]

PMID:
31425670
13.

Outcomes of an international multicenter registry on EUS-guided gallbladder drainage in patients at high risk for cholecystectomy.

Teoh AY, Perez-Miranda M, Kunda R, Lee SS, Irani S, Yeaton P, Sun S, Baron TH, Moon JH, Holt B, Khor CJL, Rerknimitr R, Bapaye A, Chan SM, Choi HJ, James TW, Kongkam P, Lee YN, Parekh P, Ridtitid W, Serna-Higuera C, Tan DMY, Torres-Yuste R.

Endosc Int Open. 2019 Aug;7(8):E964-E973. doi: 10.1055/a-0915-2098. Epub 2019 Jul 24.

14.

Covalent conjugation of bioactive peptides to graphene oxide for biomedical applications.

Eckhart KE, Holt BD, Laurencin MG, Sydlik SA.

Biomater Sci. 2019 Aug 20;7(9):3876-3885. doi: 10.1039/c9bm00867e.

PMID:
31309944
15.

Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM-85.

Sly PD, Galbraith S, Islam Z, Holt B, Troy N, Holt PG.

J Allergy Clin Immunol. 2019 Sep;144(3):870-872.e11. doi: 10.1016/j.jaci.2019.05.032. Epub 2019 Jun 8. No abstract available.

PMID:
31185221
16.

Functional Graphenic Materials That Seal Condenser Tube Leaks in Situ.

Arnold AM, Crytzer KR, Holt BD, Sydlik SA.

ACS Appl Mater Interfaces. 2019 Jun 12;11(23):20881-20887. doi: 10.1021/acsami.9b05313. Epub 2019 Jun 4.

PMID:
31117460
17.

Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations.

Geneugelijk K, Thus KA, van Deutekom HWM, Calis JJA, Borst E, Keşmir C, Oudshoorn M, van der Holt B, Meijer E, Zeerleder S, de Groot MR, von dem Borne PA, Schaap N, Cornelissen J, Kuball J, Spierings E.

Front Immunol. 2019 Apr 24;10:880. doi: 10.3389/fimmu.2019.00880. eCollection 2019.

18.

Non-invasive early detection of acute transplant rejection via nanosensors of granzyme B activity.

Mac QD, Mathews DV, Kahla JA, Stoffers CM, Delmas OM, Holt BA, Adams AB, Kwong GA.

Nat Biomed Eng. 2019 Apr;3(4):281-291. doi: 10.1038/s41551-019-0358-7. Epub 2019 Feb 18.

19.

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.

Wester R, van der Holt B, Asselbergs E, Zweegman S, Kersten MJ, Vellenga E, van Marwijk Kooy M, de Weerdt O, Minnema M, Lonergan S, Palumbo A, Lokhorst H, Broijl A, Sonneveld P.

Haematologica. 2019 Nov;104(11):2265-2273. doi: 10.3324/haematol.2018.205476. Epub 2019 Apr 4.

20.

Phosphate graphene as an intrinsically osteoinductive scaffold for stem cell-driven bone regeneration.

Arnold AM, Holt BD, Daneshmandi L, Laurencin CT, Sydlik SA.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):4855-4860. doi: 10.1073/pnas.1815434116. Epub 2019 Feb 22.

21.

The impact of terrain on lower limb bone structure.

Holt B, Whittey E.

Am J Phys Anthropol. 2019 Apr;168(4):729-743. doi: 10.1002/ajpa.23790. Epub 2019 Feb 16.

PMID:
30771265
22.

Emergency Department Observation Unit Utilization Among Older Patients With Chest Pain.

Madsen T, Perkins R, Holt B, Carlson M, Steenblik J, Bossart P, Hartsell S.

Crit Pathw Cardiol. 2019 Mar;18(1):19-22. doi: 10.1097/HPC.0000000000000166.

PMID:
30747761
23.

Personalized Transcriptomics Reveals Heterogeneous Immunophenotypes in Children with Viral Bronchiolitis.

Jones AC, Anderson D, Galbraith S, Fantino E, Gutierrez Cardenas D, Read JF, Serralha M, Holt BJ, Strickland DH, Sly PD, Bosco A, Holt PG.

Am J Respir Crit Care Med. 2019 Jun 15;199(12):1537-1549. doi: 10.1164/rccm.201804-0715OC.

PMID:
30562046
24.

Can Nurturing the Young Be the Key to Tackling Chronic Diseases in the Old? A Narrative Review With a Global Perspective.

Holt B, Kaviani N, Sheth M, van Driel M.

Ochsner J. 2018 Winter;18(4):364-369. doi: 10.31486/toj.18.0054. Review.

25.

Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?

Brooimans RA, van der Velden VHJ, Boeckx N, Slomp J, Preijers F, Te Marvelde JG, Van NM, Heijs A, Huys E, van der Holt B, de Greef GE, Kelder A, Schuurhuis GJ.

Leuk Res. 2019 Jan;76:39-47. doi: 10.1016/j.leukres.2018.11.014. Epub 2018 Nov 27.

26.

The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.

de Greef GE, Braakman E, van der Holt B, Janssen JJWM, Petersen E, Vucinic V, Thuss N, Grootes M, Cornelissen JJ.

Transfusion. 2019 Jan;59(1):316-324. doi: 10.1111/trf.15037. Epub 2018 Dec 11.

PMID:
30548284
27.

A systematic description of the post-EMR defect to identify risk factors for clinically significant post-EMR bleeding in the colon.

Desomer L, Tate DJ, Bahin FF, Awadie H, Chiang B, Holt B, Byth K, Bourke MJ.

Gastrointest Endosc. 2019 Mar;89(3):614-624. doi: 10.1016/j.gie.2018.11.023. Epub 2018 Nov 29.

PMID:
30503846
28.

An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis.

Bang JY, Arnoletti JP, Holt BA, Sutton B, Hasan MK, Navaneethan U, Feranec N, Wilcox CM, Tharian B, Hawes RH, Varadarajulu S.

Gastroenterology. 2019 Mar;156(4):1027-1040.e3. doi: 10.1053/j.gastro.2018.11.031. Epub 2018 Nov 16.

29.

Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study.

Koedijk MS, Heijmen BJM, Groot Koerkamp B, Eskens FALM, Sprengers D, Poley JW, van Gent DC, van der Laan LJW, van der Holt B, Willemssen FEJA, Méndez Romero A.

BMJ Open. 2018 Oct 15;8(10):e020731. doi: 10.1136/bmjopen-2017-020731.

30.

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.

van de Donk NW, van der Holt B, Minnema MC, Vellenga E, Croockewit S, Kersten MJ, von dem Borne PA, Ypma P, Schaafsma R, de Weerdt O, Klein SK, Delforge M, Levin MD, Bos GM, Jie KG, Sinnige H, Coenen JL, de Waal EG, Zweegman S, Sonneveld P, Lokhorst HM.

Lancet Haematol. 2018 Oct;5(10):e479-e492. doi: 10.1016/S2352-3026(18)30149-2.

PMID:
30290905
31.

Corrigendum to "Stormwater runoff plumes in the Southern California Bight: A comparison study with SAR and MODIS imagery" [Mar. Pollut. Bull. 118 (1-2) (2017) 141-154].

Holt B, Trinh R, Gierach MM.

Mar Pollut Bull. 2017 Aug 15;121(1-2):435. doi: 10.1016/j.marpolbul.2017.05.068. Epub 2017 Jun 7. No abstract available.

PMID:
30251649
32.

Developmental regulation of type 1 and type 3 interferon production and risk for infant infections and asthma development.

Holt PG, Mok D, Panda D, Renn L, Fabozzi G, deKlerk NH, Kusel MMH, Serralha M, Hollams EM, Holt BJ, Sly PD, Rabin RL.

J Allergy Clin Immunol. 2019 Mar;143(3):1176-1182.e5. doi: 10.1016/j.jaci.2018.08.035. Epub 2018 Sep 12.

PMID:
30217468
33.

Airway Microbiota Dynamics Uncover a Critical Window for Interplay of Pathogenic Bacteria and Allergy in Childhood Respiratory Disease.

Teo SM, Tang HHF, Mok D, Judd LM, Watts SC, Pham K, Holt BJ, Kusel M, Serralha M, Troy N, Bochkov YA, Grindle K, Lemanske RF Jr, Johnston SL, Gern JE, Sly PD, Holt PG, Holt KE, Inouye M.

Cell Host Microbe. 2018 Sep 12;24(3):341-352.e5. doi: 10.1016/j.chom.2018.08.005.

34.

Ion Velocity Measurements for the Ionospheric Connections Explorer.

Heelis RA, Stoneback RA, Perdue MD, Depew MD, Morgan WA, Mankey MW, Lippincott CR, Harmon LL, Holt BJ.

Space Sci Rev. 2017 Oct;212(1-2):615-629. doi: 10.1007/s11214-017-0383-3. Epub 2017 Jul 20.

35.

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.

Holt BA, Mac QD, Kwong GA.

J Vis Exp. 2018 Jul 16;(137). doi: 10.3791/57937.

36.

NUCLEAR FACTOR-Y: still complex after all these years?

Myers ZA, Holt BF 3rd.

Curr Opin Plant Biol. 2018 Oct;45(Pt A):96-102. doi: 10.1016/j.pbi.2018.05.015. Epub 2018 Jun 11. Review.

PMID:
29902675
37.

Bone functional adaptation does not erase neutral evolutionary information.

Agostini G, Holt BM, Relethford JH.

Am J Phys Anthropol. 2018 Jul;166(3):708-729. doi: 10.1002/ajpa.23460. Epub 2018 Apr 23.

PMID:
29683479
38.

Workplace bullying in risk and safety professionals.

Brewer G, Holt B, Malik S.

J Safety Res. 2018 Feb;64:129-133. doi: 10.1016/j.jsr.2017.12.015. Epub 2018 Jan 17.

PMID:
29636161
39.

A global mismatch in the protection of multiple marine biodiversity components and ecosystem services.

Lindegren M, Holt BG, MacKenzie BR, Rahbek C.

Sci Rep. 2018 Mar 6;8(1):4099. doi: 10.1038/s41598-018-22419-1.

40.

Experimental L-Band Airborne SAR for Oil Spill Response at Sea and in Coastal Waters.

Jones CE, Holt B.

Sensors (Basel). 2018 Feb 22;18(2). pii: E641. doi: 10.3390/s18020641.

41.

Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial.

Kaufmann R, Halm JA, Eker HH, Klitsie PJ, Nieuwenhuizen J, van Geldere D, Simons MP, van der Harst E, van 't Riet M, van der Holt B, Kleinrensink GJ, Jeekel J, Lange JF.

Lancet. 2018 Mar 3;391(10123):860-869. doi: 10.1016/S0140-6736(18)30298-8. Epub 2018 Feb 17.

PMID:
29459021
42.

Aqueous Zinc Compounds as Residual Antimicrobial Agents for Textiles.

Holt BA, Gregory SA, Sulchek T, Yee S, Losego MD.

ACS Appl Mater Interfaces. 2018 Mar 7;10(9):7709-7716. doi: 10.1021/acsami.7b15871. Epub 2018 Feb 26.

PMID:
29433308
43.

Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation.

Duinhouwer LE, Beije N, van der Holt B, Rijken-Schelen A, Lamers CH, Somers J, Braakman E, Cornelissen JJ.

Bone Marrow Transplant. 2018 Jun;53(6):673-682. doi: 10.1038/s41409-018-0103-y. Epub 2018 Feb 9.

PMID:
29426829
44.

Contraceptive Method Use and Chlamydia Positivity Among California Family Planning Clients: The Case for New Multipurpose Prevention Technologies.

Hunter LA, Nelson L, Chow JM, Holt BY, Bauer HM.

J Womens Health (Larchmt). 2018 Jun;27(6):768-774. doi: 10.1089/jwh.2017.6558. Epub 2018 Jan 29.

PMID:
29377757
45.

Correction: Trabecular bone in the calcaneus of runners.

Best A, Holt B, Troy KL, Hamill J.

PLoS One. 2017 Dec 27;12(12):e0190553. doi: 10.1371/journal.pone.0190553. eCollection 2017.

46.

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human.

Aerts JGJV, de Goeje PL, Cornelissen R, Kaijen-Lambers MEH, Bezemer K, van der Leest CH, Mahaweni NM, Kunert A, Eskens FALM, Waasdorp C, Braakman E, van der Holt B, Vulto AG, Hendriks RW, Hegmans JPJJ, Hoogsteden HC.

Clin Cancer Res. 2018 Feb 15;24(4):766-776. doi: 10.1158/1078-0432.CCR-17-2522. Epub 2017 Dec 12.

47.

Can we refine body mass estimations based on femoral head breadth?

Niskanen M, Junno JA, Maijanen H, Holt B, Sladék V, Berner M.

J Hum Evol. 2018 Feb;115:112-121. doi: 10.1016/j.jhevol.2017.10.015. Epub 2017 Dec 7.

PMID:
29223292
48.

The effect of age and body composition on body mass estimation of males using the stature/bi-iliac method.

Junno JA, Niskanen M, Maijanen H, Holt B, Sladek V, Niinimäki S, Berner M.

J Hum Evol. 2018 Feb;115:122-129. doi: 10.1016/j.jhevol.2017.10.006. Epub 2017 Nov 20.

PMID:
29167014
49.

Trabecular bone in the calcaneus of runners.

Best A, Holt B, Troy L, Hamill J.

PLoS One. 2017 Nov 15;12(11):e0188200. doi: 10.1371/journal.pone.0188200. eCollection 2017. Erratum in: PLoS One. 2017 Dec 27;12 (12 ):e0190553.

50.

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

Goldschmidt H, Lokhorst HM, Mai EK, van der Holt B, Blau IW, Zweegman S, Weisel KC, Vellenga E, Pfreundschuh M, Kersten MJ, Scheid C, Croockewit S, Raymakers R, Hose D, Potamianou A, Jauch A, Hillengass J, Stevens-Kroef M, Raab MS, Broijl A, Lindemann HW, Bos GMJ, Brossart P, van Marwijk Kooy M, Ypma P, Duehrsen U, Schaafsma RM, Bertsch U, Hielscher T, Jarari L, Salwender HJ, Sonneveld P.

Leukemia. 2018 Feb;32(2):383-390. doi: 10.1038/leu.2017.211. Epub 2017 Jul 4.

PMID:
28761118

Supplemental Content

Support Center